Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/23338
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2021-12-16T12:01:04Z | - |
dc.date.available | 2021-12-16T12:01:04Z | - |
dc.date.issued | 2011-08 | - |
dc.identifier.citation | Gasanov, F. vd. (2011). "The effects of tadalafil on renal ischemia reperfusion injury: An experimental study". Bosnian Journal of Basic Medical Sciences, 11(3), 158-162. | en_US |
dc.identifier.issn | 1512-8601 | - |
dc.identifier.uri | https://doi.org/10.17305/bjbms.2011.2567 | - |
dc.identifier.uri | https://www.bjbms.org/ojs/index.php/bjbms/article/view/2567 | - |
dc.identifier.uri | http://hdl.handle.net/11452/23338 | - |
dc.description.abstract | Many pharmacological agents were investigated for the prevention of renal ischemic reperfusion (I/R) injury as well as the phosphodiesterase (PDE) inhibitors. The aim of the study was to examine the possible renoprotective effect of a member in this family, tadalafil (Td) on I/R injury. Thirty-six Sprague Dawley rats were allocated to six groups as; control, sham, ischemia (I), ischemia/reperfusion (I/R), Td pretreatment ischemia (Td/I) and Td pretreatment ischemia/reperfusion (Td/IR) groups. Right nephrectomy was performed in all groups. Td was dissolved in saline solution and given as a single dose (1mg/kg) through an orogastrictube 60 min before the operation in the Td pretreatment groups. In ischemia group the left renal pedicle was occluded for 45 minutes and after than underwent left nephrectomy. In I/R group left renal pedicle was occluded for 45 minutes, reperfused for I hour and after then underwent nephrectomy. The left kidneys were evaluated after standard laboratory procedures with regard to tubular morphology, and leukocyte infiltration. The data were analyzed by using Kruskal Wallis test to determine differences among the groups. A p value of < 0.05 was considered significant. Renal tubular damage was significant increased in the ischemia and I/R group (Groups III and IV) when compared to those in the sham group (Group II), (p = 0.004, 0.004, respectively). Tubular damage, in the Td pretreatment ischemia (Td/I) (Group V) and Td pretreatment ischemia/reperfusion (Td/IR) (Group VI) were less than that in the ischemia group (Group III) (p=0.0010, p=0.025, respectively). Td administration prior to the renal I/R injury attenuated these morphological disarrangements, which were observed in renal I/R. Tubular necrosis, which may be considered as an important issue of the developing renal injury, was also completely prevented with Td administration. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Assoc Basic Meical Sci Federarion Bosbia & Herzegovina Sara | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Research & experimental medicine | en_US |
dc.subject | Kidney | en_US |
dc.subject | Tadalafil | en_US |
dc.subject | Rat | en_US |
dc.subject | Ischemia/reperfusion injury | en_US |
dc.subject | Cyclic-gmp | en_US |
dc.subject | Rats | en_US |
dc.subject | Inhibition | en_US |
dc.subject | Failure | en_US |
dc.subject | Kidney | en_US |
dc.subject | Pde5 | en_US |
dc.subject | Neutrophils | en_US |
dc.subject | Dysfunction | en_US |
dc.subject | Olprinone | en_US |
dc.title | The effects of tadalafil on renal ischemia reperfusion injury: An experimental study | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000295237200004 | tr_TR |
dc.identifier.scopus | 2-s2.0-80052410919 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Cerrahi Patoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Üroloji Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 158 | tr_TR |
dc.identifier.endpage | 162 | tr_TR |
dc.identifier.volume | 11 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Bosnian Journal of Basic Medical Sciences | en_US |
dc.contributor.buuauthor | Gasanov, Feyzullah | - |
dc.contributor.buuauthor | Aytaç, Berna | - |
dc.contributor.buuauthor | Vuruşkan, Hakan | - |
dc.contributor.researcherid | AAH-9746-2021 | tr_TR |
dc.identifier.pubmed | 21875417 | tr_TR |
dc.subject.wos | Medicine, research & experimental | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 56629254000 | tr_TR |
dc.contributor.scopusid | 56527372000 | tr_TR |
dc.contributor.scopusid | 6507328150 | tr_TR |
dc.subject.scopus | Phosphodiesterase V Inhibitor; Tadalafil; Sildenafil | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Dosya | Açıklama | Boyut | Biçim | |
---|---|---|---|---|
Gasanov_vd_2011.pdf | 183.17 kB | Adobe PDF | Göster/Aç |
Bu öğe kapsamında lisanslı Creative Commons License